Guggenheim analyst Jason Cassorla raised the firm’s price target on Universal Health (UHS) to $274 from $253 and keeps a Buy rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Raymond James Sees Market Cooling but These 2 Stocks Still Look Like Buys
- Universal Health price target raised to $259 from $249 at Wells Fargo
- Boeing upgraded, Charter downgraded: Wall Street’s top analyst calls
- Universal Health price target raised to $267 from $242 at Mizuho
- Universal Health upgraded to Outperform from Market Perform at Raymond James